donepezil + methylphenidate

Donepezil + methylphenidate is a combination of two pharmaceutical agents, each with distinct mechanisms of action. Donepezil is an acetylcholinesterase inhibitor primarily used to treat symptoms of Alzheimer's disease by increasing acetylcholine levels in the brain, thereby improving cognitive function and memory. Methylphenidate is a central nervous system stimulant that acts as a norepinephrine and dopamine reuptake inhibitor (NDRI), increasing the concentration of these neurotransmitters in the synaptic cleft, which enhances attention and executive function. This combination may be explored for synergistic effects on cognition or attention in neurodegenerative or neuropsychiatric conditions, though it does not have an established brand name or widespread clinical use as a fixed-dose combination.